Levetiracetam Qualigen

Levetiracetam, the active ingredient in Levetiracetam Qualigen, is an anticonvulsant presented as an oral tablet for oral use. It is indicated for the management of epilepsy, including partial‑onset, myoclonic, and primary generalized tonic‑clonic seizures, and is used in both adult and pediatric populations.

GNH USA supplies Levetiracetam Qualigen as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics across global markets, ensuring consistent availability and regulatory compliance.

Levetiracetam is an antiepileptic drug that acts on neuronal excitability to control various seizure disorders. - Epilepsy: reduces overall seizure frequency across multiple seizure types. - Partial seizures: controls focal onset seizures with or without secondary generalization. - Myoclonic seizures: diminishes sudden, brief muscle jerks. - Primary generalized tonic‑clonic seizures: prevents generalized convulsive episodes.

Levetiracetam may cause a range of adverse reactions.

Common Side Effects: - Drowsiness: feeling unusually sleepy. - Fatigue: reduced energy levels. - Dizziness: sensation of light‑headedness. - Headache: mild to moderate cranial pain. - Irritability: increased mood volatility. - Nausea: upset stomach.

Serious or Rare Side Effects: - Severe skin reactions: such as Stevens‑Johnson syndrome. - Mood changes: including depression or suicidal thoughts. - Allergic reactions: rash, swelling, or anaphylaxis. - Blood disorders: rare cases of leukopenia or thrombocytopenia. - Multi‑organ hypersensitivity: systemic inflammatory response. - Hepatic dysfunction: abnormal liver enzymes.

Levetiracetam requires careful consideration of patient‑specific factors before use. - Renal impairment: dose adjustment may be needed. - Hepatic impairment: monitor liver function. - Pregnancy: risk unknown; weigh benefits against potential risks. - Discontinuation: avoid abrupt stopping; taper under medical supervision. - Concomitant CNS depressants: monitor for enhanced sedation. - Store at room temperature: keep in original packaging, protect from moisture.

Levetiracetam can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: enzyme induction reduces levetiracetam levels. - Phenytoin: decreases levetiracetam plasma concentration. - Phenobarbital: lowers levetiracetam exposure.

Moderate Interactions (Monitor Closely): - Alcohol: may increase central nervous system depression. - Other CNS depressants: enhanced drowsiness. - Fluoroquinolone antibiotics: potential increase in neuropsychiatric effects. - NSAIDs: monitor for renal function. - Certain antidepressants: watch for mood alterations.